TherapeuticsMD (TXMD) Capital Expenditures Growth (5y) (2016 - 2023)
TherapeuticsMD (TXMD) Capital Expenditures Growth (5y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 72.63% |
| Sep 30, 2023 | -105.94% |
| Jun 30, 2023 | -94.28% |
| Mar 31, 2023 | -6.72% |
| Dec 31, 2022 | 211.49% |
| Jun 30, 2022 | -35.81% |
| Mar 31, 2022 | 8.58% |
| Sep 30, 2021 | -29.49% |
| Jun 30, 2021 | -26.46% |
| Mar 31, 2021 | -3.29% |
| Dec 31, 2020 | 2.33% |
| Jun 30, 2019 | 157.94% |
| Mar 31, 2019 | 61.76% |
| Dec 31, 2018 | 54.66% |
| Sep 30, 2018 | 89.14% |
| Mar 31, 2018 | 3.27% |
| Dec 31, 2017 | 65.43% |
| Jun 30, 2017 | -25.11% |
| Mar 31, 2017 | -2.98% |
| Sep 30, 2016 | 72.27% |